The lack of significant changes in ANGPTL5 levels between obese and non-obese subjects with T2D may be due to effect of antidiabetic medication and a conscious effort to control obesity. The gene discussed is ANGPTL5; the disease is obesity due to melanocortin 4 receptor deficiency.